Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Denali Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 12 Apr 2023 | Biogen Enters into Licensing Agreement with Denali Therapeutics | Licensing Agreement |
Biogen Inc
|
Denali Therapeutics Inc |
| 30 Nov 2022 | Denali Therapeutics Inc Enters Phase I Clinical Trial Agreement with Simbec-Orion Group Ltd for RD-76535958 (GDCT0485784) | Contract Service Agreement |
Denali Therapeutics Inc
|
Simbec-Orion Group Ltd
|
| 18 Oct 2022 | Denali Therapeutics Raises USD316 Million in Public Offering of Shares | Equity Offering | - |
Denali Therapeutics Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer